Current management of PF-ILDs and new horizons
Video degli interventi del virtual Top Seminar in IPF/ILD 2020
![]() |
Gestione attuale delle PF-ILDs e nuovi orizzonti:
ILD with the progressive fibrosing phenotype – dr Marco Sebastiani
Characteristics and current approach in patients with PF-ILD in a real-world setting – dr Fabrizio Luppi
ILD with the progressive fibrosing phenotype – dr Marco Sebastiani
Characteristics and current approach in patients with PF-ILD in a real-world setting – dr Fabrizio Luppi
ARTICOLI CORRELATI
![img-card img-card](/it/medaffairs/sites/default/files/2022-09/image-card.png)
APPROFONDIMENTI
Emerging diagnostic approaches to patients with ILD
Emerging diagnostic approaches to patients with ILD
![img-card img-card](/it/medaffairs/sites/default/files/2022-09/image-card.png)
APPROFONDIMENTI
Real life Nintedanib in IPF
Video degli interventi del virtual Top Seminar in IPF/ILD 2020
![img-card img-card](/it/medaffairs/sites/default/files/2022-09/image-card.png)
APPROFONDIMENTI
Ruolo di Reumatologo e Pneumologo nelle ILD secondarie a malattie reumatiche autoimmuni
Dr.ssa S Cerri e Dr.ssa A Manfredi, AOU Policlinico di Modena, raccontano la loro esperienza – web meeting
![img-card img-card](/it/medaffairs/sites/default/files/2022-09/image-card.png)
APPROFONDIMENTI
Nintedanib in IPF: post hoc analysis of the Italian FIBRONET observational study
Videopillola a cura di Prof. Venerino Poletti, direttore del Dipartimento Toracico dell’Ausl della Romagna, della Pneumologia all’Ospedale Morgagni di Forlì e Full Professor ad Aarhus (Danimarca)